← All trials
NCT06479720
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 16, 2022
- Primary completion
- Dec 31, 2024
- Completion date
- Jun 30, 2025
- First posted
- Jun 28, 2024
- Last posted
- Jul 17, 2024
- Enrollment
- 300
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Mackay Medical CollegeLead sponsor
- Mackay Medical CollegeSponsor investigator
- Mackay Medical CollegeOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.